DMAC
DiaMedica Therapeutics Inc
Price:  
5.85 
USD
Volume:  
184,869.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DMAC Stock Forecast & Price Target

DMAC Stock Price Forecast

The average stock forecast for DiaMedica Therapeutics Inc (DMAC) in the next 12 months is 15.81 USD. This price target corresponds to an upside of 175.92%. The range of stock forecasts for DMAC is 11.11 - 26.25 USD. Based on the ratings of 11 analysts, the consensus recommendation for DMAC is BUY.
Target Low Average Median High
Price (USD) 11.11 15.81 13.26 26.25
Upside 93.89% 175.92% 131.41% 358.12%

Recommendation Trends

The latest consensus rating for DMAC is "BUY". This is the average recommendation of 11 analysts: 0 strong sell, 0 sell, 1 hold, 8 buy, 2 strong buy. In the previous period, 11 analysts also majorly recommmended "BUY" for DMAC.

DMAC Financial Stock Forecast

Revenue This Year
-M
from -M
Revenue Next Year
-M
from -M
EPS This Year
-0.81
32.79%
from -0.61
EPS Next Year
-0.86
6.82%
from -0.81